Trial Profile
Evaluation of abdominal symptoms and gastrointestinal mucosal injuries in patients receiving oral anticoagulant dabigatran
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2011
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Famotidine; Rabeprazole; Rebamipide
- Indications Thrombosis
- Focus Adverse reactions
- 16 Sep 2011 New trial record